Selection of a highly invasive neuroblastoma cell population through long-term human cytomegalovirus infection

Oncogenesis

Volumn 1, Issue 4, 2012, Pages

  Michaelis, M ^a,g   Barth, S ^b   Breitling, R ^c,d   Bruch, J ^e   Steinberger, D ^e   Rothweiler, F ^a   Hackmann, K ^f   Schrock E ^f   Doerr, H W ^a   Griffin, D K ^g   Cinatl, J ^a,a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b Blue drugs GmbH   (Germany)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d UNIVERSITY OF GRONINGEN   (Netherlands)

^e Biologis Center for Human Genetics   (Germany)

^f DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^g UNIVERSITY OF KENT   (United Kingdom)

Author keywords

cancer cell malignancy; human cytomegalovirus; long term infection; neuroblastoma; oncomodulation

Indexed keywords

EID: 84868277678     PISSN: None     EISSN: 21579024     Source Type: Journal    
DOI: 10.1038/oncsis.2012.10     Document Type: Article

References (48)

1. Söderberg-Nauclé r C. HCMV microinfections in inflammatory diseases and cancer. J Clin Virol 2008; 41: 218-223.
2. Michaelis M, Doerr HW, Cinatl Jr J. The story of human cytomegalovirus and cancer: increasing evidence and open questions. Neoplasia 2009; 11: 1-9.
3. Michaelis M, Baumgarten P, Mittelbronn M, Hernáiz Driever P, Doerr HW, Cinatl Jr J. Oncomodulation by human cytomegalovirus: Novel clinical findings open new roads. Med Microbiol Immunol 2011; 200: 1-5.
4. Moore PS, Chang Y. Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nat Rev Cancer 2010; 10: 878-889.
5. Cinatl Jr J, Cinatl J, Radsak K, Rabenau H, Weber B, Novak M et al. Replication of human cytomegalovirus in a rhabdomyosarcoma cell line depends on the state of differentiation of the cells. Arch Virol 1994; 138: 391-401. (Pubitemid 2162614)
6. Cinatl Jr J, Cinatl J, Vogel JU, Rabenau H, Kornhuber B, Doerr HW. Modulatory effects of human cytomegalovirus infection on malignant properties of cancer cells. Intervirology 1996; 39: 259-269. (Pubitemid 27105489)
7. Cinatl Jr J, Vogel JU, Cinatl J, Weber B, Rabenau H, Novak M et al. Long-term productive human cytomegalovirus infection of a human neuroblastoma cell line. Int J Cancer 1996; 65: 90-96. (Pubitemid 26027541)
8. Barami K. Oncomodulatory mechanisms of human cytomegalovirus in gliomas. J Clin Neurosci 2010; 17: 819-823.
9. Kofman A, Marcinkiewicz L, Dupart E, Lyshchev A, Martynov B, Ryndin A et al. The roles of viruses in brain tumor initiation and oncomodulation. J Neurooncol 2011; 105: 451-466.
10. Maussang D, Verzijl D, van Walsum M, Leurs R, Holl J, Pleskoff O et al. Human cytomegalovirus-encoded chemokine receptor US28 promotes tumorigenesis. Proc Natl Acad Sci USA 2006; 103: 13068-13073. (Pubitemid 44338917)
11. Bongers G, Maussang D, Muniz LR, Noriega VM, Fraile-Ramos A, Barker N et al. The cytomegalovirus-encoded chemokine receptor US28 promotes intestinal neoplasia in transgenic mice. J Clin Invest 2010; 120: 3969-3978.
12. Soroceanu L, Cobbs CS. Is HCMV a tumor promotor? Virus Res 2011; 157: 193-203.
13. Harkins LE, Matlaf LA, Soroceanu L, Klemm K, Britt WJ, Wang W et al. Detection of human cytomegalovirus in normal and neoplastic breast epithelium. Herpesviridae 2010; 1: 8.
14. Dziurzynski K, Wei J, Qiao W, Hatiboglu MA, Kong LY, Wu A et al. Glioma-associated cytomegalovirus mediates subversion of the monocyte lineage to a tumor propagating phenotype. Clin Cancer Res 2011; 17: 4642-4649.
15. Shen Y, Zhu H, Shenk T. Human cytomagalovirus IE1 and IE2 proteins are mutagenic and mediate "hit-and-run" oncogenic transformation in cooperation with the adenovirus E1A proteins. Proc Natl Acad Sci USA 1997; 94: 3341-3345.
16. Baryawno N, Rahbar A, Wolmer-Solberg N, Taher C, Odeberg J, Darabi A et al. Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic target. J Clin Invest 2011; 121: 4043-4055.
17. Ranganathan P, Clark PA, Kuo JS, Salamat MS, Kalejta RF. Significant association of multiple human cytomegalovirus genomic loci with glioblastoma multiforme samples. J Virol 2012; 86: 854-864.
18. Scheurer ME, Bondy ML, Aldape KD, Albrecht T, El-Zein R. Detection of human cytomegalovirus in different histological types of gliomas. Acta Neuropathol 2008; 116: 79-86.
19. Saddawi-Konefka R, Crawford JR. Chronic viral infection and primary central nervous system malignancy. J Neuroimmune Pharmacol 2010; 5: 387-403.
20. Strååt K, Liu C, Rahbar A, Zhu Q, Liu L, Wolmer-Solberg N et al. Activation of telomerase by human cytomegalovirus. J Natl Cancer Inst 2009; 101: 488-497.
21. Slinger E, Maussang D, Schreiber A, Siderius M, Rahbar A, Fraile-Ramos A et al. HCMV-encoded chemokine receptor US28 mediates proliferative signaling through the IL-6-STAT3 axis. Sci Signal 2010; 3: ra58.
22. Wertheim P, Voute PA. Neuroblastoma Wilms' tumor, and cytomegalovirus. J Natl Cancer Inst 1976; 57: 701-703.
23. Nigro G, Schiavetti A, Booth JC, Clerico A, Dominici C, Krzysztofiak A et al. Cytomegalovirus-associated stage 4S neuroblastoma relapsed stage 4. Med Pediatr Oncol 1995; 24: 200-203.
24. Cinatl Jr J, Cinatl J, Vogel JU, Kotchetkov R, Driever PH, Kabickova H et al. Persistent human cytomegalovirus infection induces drug resistance and alteration of programmed cell death in human neuroblastoma cells. Cancer Res 1998; 58: 367-372. (Pubitemid 28047081)
25. Hoever G, Vogel JU, Lukashenko P, Hofmann WK, Komor M, Doerr HW et al. Impact of persistent cytomegalovirus infection on human neuroblastoma cell gene expression. Biochem Biophys Res Commun 2005; 326: 395-401. (Pubitemid 39593560)
26. Cinatl Jr J, Cinatl J, Kotchetkov R, Vogel JU, Woodcock BG, Matousek J et al. Bovine seminal ribonuclease selectively kills human multidrug-resistant neuroblastoma cells via induction of apoptosis. Int J Oncol 1999; 15: 1001-1009.
27. Cinatl Jr J, Margraf S, Vogel JU, Scholz M, Cinatl J, Doerr HW. Human cytomegalovirus circumvents NF-kappa B dependence in retinal pigment epithelial cells. J Immunol 2001; 167: 1900-1908. (Pubitemid 32747494)
28. Scholz M, Blaheta RA, Wittig B, Cinatl J, Vogel JU, Doerr HW et al. Cytomegalovirus-infected neuroblastoma cells exhibit augmented invasiveness mediated by beta1alpha5 integrin (VLA-5). Tissue Antigens 2000; 55: 412-421. (Pubitemid 30316151)
29. Oberthuer A, Berthold F, Warnat P, Hero B, Kahlert Y, Spitz R et al. Customized oligonucleotide microarray gene expression-based classification of neuroblastoma patients outperforms current clinical risk stratification. J Clin Oncol 2006; 24: 5070-5078. (Pubitemid 46631411)
30. Asgharzadeh S, Pique-Regi R, Sposto R, Wang H, Yang Y, Shimada H et al. Prognostic significance of gene expression profiles of metastatic neuroblastomas lacking MYCN gene amplification. J Natl Cancer Inst 2006; 98: 1193-1203. (Pubitemid 44390990)
31. Sanchez V, Spector DH. Subversion of cell cycle regulatory pathways. Curr Top Microbiol Immunol 2008; 325: 243-262.
32. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-674.
33. Luo MH, Fortunato EA. Long-term infection and shedding of human cytomegalovirus in T98G glioblastoma cells. J Virol 2007; 81: 10424-10436. (Pubitemid 47463316)
34. Furukawa T. A variant of human cytomegalovirus derived from a persistently infected culture. Virology 1984; 137: 191-194. (Pubitemid 14068868)
35. Ogura T, Tanaka J, Kamiya S, Sato H, Ogura H, Hatano M. Human cytomegalovirus persistent infection in a human central nervous system cell line: production of a variant virus with different growth characteristics. J Gen Virol 1986; 67: 2605-2616. (Pubitemid 17197591)
36. Lambert G, Estévez-Salmeron L, Oh S, Liao D, Emerson BM, Tlsty TD et al. An analogy between the evolution of drug resistance in bacterial communities and malignant tissues. Nat Rev Cancer 2011; 11: 375-382.
37. Knoblach T, Grandel B, Seiler J, Nevels M, Paulus C. Human cytomegalovirus IE1 protein elicits a type ii interferon-like host cell response that depends on activated STAT1 but not interferon-g. PLoS Pathog 2011; 7: e1002016.
38. Fortunato EA, Spector DH. Viral induction of site-specific chromosome damage. Rev Med Virol 2003; 13: 21-37. (Pubitemid 36125503)
39. Siew VK, Duh CY, Wang SK. Human cytomegalovirus UL76 induces chromosome aberrations. J Biomed Sci 2009; 16: 107.
40. Caron C, Col E, Khochbin S. The viral control of cellular acetylation signaling. Bioessays 2003; 25: 58-65. (Pubitemid 36093326)
41. Nevels M, Paulus C, Shenk T. Human cytomegalovirus immediate-early 1 protein facilitates viral replication by antagonizing histone deacetylation. Proc Natl Acad Sci USA 2004; 101: 17234-17239. (Pubitemid 39627803)
42. Cinatl Jr J, Nevels M, Paulus C, Michaelis M. Activation of telomerase in glioma cells by human cytomegalovirus: another piece of the puzzle. J Natl Cancer Inst 2009; 101: 441-443.
43. Greaves M, Maley CC. Clonal evolution in cancer. Nature 2012; 481: 306-313.
44. Michaelis M, Paulus C, Löschmann N, Dauth S, Stange E, Doerr HW et al. The multitargeted kinase inhibitor sorafenib inhibits human cytomegalovirus replication. Cell Mol Life Sci 2011; 68: 1079-1090.
45. Smyth GK. Linear models and empirical Bayes methods for assessing dierential expression in microarray experiments. Statist Appl Genet Mol Biol 2004; 3 (Article 3).
46. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B 1995; 57: 289-300.
47. Mi H, Guo N, Kejariwal A, Thomas PD. PANTHER version 6: protein sequence and function evolution data with expanded representation of biological pathways. Nucleic Acids Res 2007; 35: D247-D252. (Pubitemid 46056208)
48. Cho RJ, Campbell MJ. Transcription genomes, function. Trends Genet 2000; 16: 409-415.